Status:
COMPLETED
Behavioral Treatment of Drug Abuse in Severe and Persistent Mental Illness (SPMI) Patients
Lead Sponsor:
University of Maryland, Baltimore
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Schizophrenia
Mood Disorders
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The main purpose of this study is to determine if the multifaceted treatment for substance abuse in dual disordered patients is more effective in reducing drug use than a supportive control treatment....
Detailed Description
Drug and alcohol abuse by people with severe and persistent mental illness (SPMI) is one of the most significant problems facing the public mental health system. We have been conducting a project to d...
Eligibility Criteria
Inclusion
- a diagnosis of schizophrenia or schizoaffective disorder or a diagnosis of other severe mental disorder including bipolar disorder, major depression, or severe anxiety disorder (by definition, the patient has worked 25% or less of the past year; and/or the patient receives payment for mental disability)
- a diagnosis of current dependence for opiates, cocaine, or marijuana
- ability and willingness to attend treatment sessions for 6 months
- ability and willingness to provide consent to participate
- enrolled in mental health care
Exclusion
- documented history of severe neurological disorder or severe head trauma with loss of consciousness
- severe or profound mental retardation as indicated by chart review
- inability to effectively participate in the baseline assessments due to intoxication or psychiatric symptoms on two successive appointments
- had a substantial trial in either intervention of the Evaluation of Behavioral Treatment for Substance Abuse in Schizophrenia protocol (H-20680)
- inability to attend group sessions due to transportation or other logistical problems
- inability to attend scheduled treatment sessions on a regular basis for any reason, or to appropriately participate in research activities due to behavioral or psychiatric problems
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2010
Estimated Enrollment :
293 Patients enrolled
Trial Details
Trial ID
NCT00295139
Start Date
January 1 2005
End Date
March 1 2010
Last Update
February 18 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Care for the Homeless
Baltimore, Maryland, United States, 21201
2
University of Maryland, Baltimore
Baltimore, Maryland, United States, 21201
3
VA Maryland Health Care System
Baltimore, Maryland, United States, 21201
4
Mosaic Community Services
Catonsville, Maryland, United States, 21228